Longeveron Inc
Change company Symbol lookup
Select an option...
LGVN Longeveron Inc
IBM International Business Machines Corp
COTY Coty Inc
KURA Kura Oncology Inc
UBQU Ubiquitech Software Corp
VZ Verizon Communications Inc
KRTX Karuna Therapeutics Inc
SNSE Sensei Biotherapeutics Inc
ALGS Aligos Therapeutics Inc
SRRA Sierra Oncology Inc
Go

Health Care : Biotechnology |
Company profile

Longeveron Inc., formerly Longeveron LLC, is a clinical stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. Its lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. It is sponsoring clinical trials in various indications, including Aging Frailty, Alzheimer's disease (AD), the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS) and hypoplastic left heart syndrome (HLHS). It is developing Lomecel-B as a therapy for Aging Frailty and is being designed to reduce inflammation associated with Aging Frailty and to promote an anti-inflammatory state by releasing anti-inflammatory molecules, which can promote physiological restoration to a more normal state. It is conducting two multicenter trials in the United States (U.S.)

Price
Delayed
$21.40
Day's Change
1.82 (9.30%)
Bid
--
Ask
--
B/A Size
--
Day's High
23.71
Day's Low
19.30
Volume
(Light)

Today's volume of 5,522,617 shares is on pace to be much lighter than LGVN's 10-day average volume of 22,513,671 shares.

5,522,617
  • Prev Close
    19.58
  • Today's Open
    19.58
  • Day's Range
    19.30-23.71
  • Avg Vol (10-day)
    22.5M
  • Last (time)
    2:16p ET 12/08/21
  • Last (size)
    300
  • 52-Wk Range
    2.84 - 45.00
    LowHigh
  • (11/17/21 - 11/24/21)
    653.49%
  • 214.6%
  • Market Cap
    433.8M
  • Shares Outstanding
    20.3M
  • -0.77
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 8.45
  • (% of float 11/15/21)
    8.99

Latest News

December 06, 2021
8:00 am ET
Globe Newswire
December 03, 2021
4:30 pm ET
Globe Newswire
10:50 am ET
PR Newswire
December 01, 2021
3:16 am ET
Globe Newswire
November 30, 2021
3:20 pm ET
Globe Newswire
8:45 am ET
PR Newswire
8:45 am ET
PR Newswire
November 22, 2021
3:42 pm ET
MarketWatch
November 18, 2021
10:57 am ET
MarketWatch
8:00 am ET
Globe Newswire
November 14, 2021
11:55 pm ET
Accesswire
November 12, 2021
2:22 pm ET
Newsfile
11:02 am ET
Accesswire
10:50 am ET
Newsfile
8:00 am ET
Accesswire
8:00 am ET
Globe Newswire
November 11, 2021
6:55 pm ET
Accesswire
November 10, 2021
2:55 pm ET
Newsfile
1:15 pm ET
Globe Newswire
10:45 am ET
Accesswire
10:00 am ET
Newsfile
November 09, 2021
3:06 pm ET
Globe Newswire
2:49 pm ET
Newsfile
1:55 pm ET
Accesswire
1:16 pm ET
Accesswire
9:20 am ET
Globe Newswire
November 08, 2021
1:04 pm ET
Newsfile
12:07 pm ET
Accesswire
11:01 am ET
Accesswire
8:30 am ET
Globe Newswire
7:40 am ET
Accesswire
November 07, 2021
10:40 pm ET
Accesswire
8:39 pm ET
Newsfile
1:15 pm ET
BusinessWire
November 05, 2021
6:05 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.